TMCnet News
Global $1.9 Bn 3D Bioprinters Market to 2025DUBLIN, October 18, 2017 /PRNewswire/ -- The "Global 3D Bioprinters Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025" report has been added to Research and Markets' offering.  The 3D bioprinters market was valued at USD 774.41 Mn in 2017, and is expected to reach USD 1,942.5 Mn by 2025, expanding at a CAGR of 18.8% from 2017 - 2025. The global 3D bioprinters market is represented by key technologies namely, syringe based 3D bioprinting, laser based 3D bioprinting, magnetic levitation 3D bioprinting, inkjet based 3D bioprinting and valve-based 3D bioprinting. Among these syringe based 3D bioprinting is the largest segment and is anticipated to maintain its lead during the forecast period 2016 - 2022. Pharmaceuticals segment accounted for a major share of 31.70% in the 3D bioprinting market. Drug development today is increasingly focusing on reducing side effects, improving treatment outcomes and deserting the one-size-fits-all' approach to medication management. Acording to market experts competition in 3D bioprinting market is low and barriers are high. Competition is low due to presence of niche opportunities in the healthcare industry and barriers are high because the research is very specialized and requires a significant amount of investment, usually by the government or private donors, while the risks to profitability remain very high. 3D Systems, Inc. and Stratasys Ltd. dominate the 3D printer applications in healthcare market. The other upcoming key players such as Organovo, Inc. and EnvisionTEC, Inc. are expected to be one of the leading players in 3D bioprinting market in the near future. Market Dynamics Drivers
Challenges
Opportunities
Key Market Movements:
Key Topics Covered:
For more information about this report visit https://www.researchandmarkets.com/research/qr3sf9/global_3d Media Contact: Research and Markets 
|